LISATA THERAPEUTICS, INC. — Director's Dealing 2012

Jun 27, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2012-06-25

Reporting Person: SCHMIEG MARTIN E (Vice President - Corporate Dev)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-06-25	Stock Option (Right to Buy)	$0.44	A	300000	Acquired	2022-06-24	Common Stock, $0.001 par value per share (300000)	Direct

Footnotes

F1: On June 25, 2012, the commencement date (the "Commenement Date") of his employment with NeoStem, Inc. (the "Company"), pursuant to his emoloyment agreement with the Issuer, the Reporting Person was granted an option to purchase 300,000 shares of the Company's common stock, par value $0.001 per share (the "Common Stock"), pursuant and subject to the terms and conditions of the Company's 2009 Equity Compensation Plan (the "Plan"). The option shall vest and become exercisable, subject to Reporting Person's continued employment with the Company, as to (i) 100,000 shares on the first anniversary of the Commencement Date; (ii) 100,000 shares on the second anniversary of the Commencement Date; and (iii) 100,000 shares upon the achievement of a specified business milestone.